Gene therapy for cystic fibrosis [10]

Lancet

Volumn 349, Issue 9060, 1997, Pages 1249-1251

  Colledge, W H ^a   Alton, E ^a   Smith, S ^a   Geddes, D ^a   Larson, J E ^a   Morrow, S L ^a   Cohen, J C ^a   Turner, G ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; BETA GALACTOSIDASE; CFTR PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; CYSTIC FIBROSIS; GENE THERAPY; JEJUNUM; LETTER; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURVIVAL; ANIMAL; FEMALE; GENE VECTOR; GENETICS; INTESTINE OBSTRUCTION; JEJUNUM DISEASE; MALE; NOTE; PHENOTYPE; PREGNANCY; SURVIVAL RATE; GENE TRANSFER; HUMAN;

ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENE THERAPY; GENETIC VECTORS; INTESTINAL OBSTRUCTION; JEJUNAL DISEASES; MALE; MICE; PHENOTYPE; PREGNANCY; SURVIVAL RATE; BETA-GALACTOSIDASE; GENE TRANSFER TECHNIQUES; HUMANS;

EID: 0030938482     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(97)26017-4     Document Type: Letter

References (4)

1. JE Larson SL Morrow L Happel JF Sharp JC Cohen Reversal of cystic fibrosis phenotype in mice by gene therapy in utero Lancet 349 1997 619 620
2. EA Eckman CU Cotton DM Kube PB Davis Dietary changes improve survival of Cftr S489X homozygous mutant mouse Am J Physiol 13 1995 L625 L630
3. WH Colledge BS Abella KW Southern Generation and characterization of a ΔF508 cystic fibrosis mouse model Nat Genet 10 1995 445 452
4. R Rozmahel M Wilschanski A Matin Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor Nat Genet 12 1996 280 287